These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 25675118)

  • 21. MicroRNAs and cancer stem cells: the sword and the shield.
    Sun X; Jiao X; Pestell TG; Fan C; Qin S; Mirabelli E; Ren H; Pestell RG
    Oncogene; 2014 Oct; 33(42):4967-77. PubMed ID: 24240682
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNAs in clinical oncology: at the crossroads between promises and problems.
    Metias SM; Lianidou E; Yousef GM
    J Clin Pathol; 2009 Sep; 62(9):771-6. PubMed ID: 19734473
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epigenetically regulated microRNAs and their prospect in cancer diagnosis.
    Kita Y; Vincent K; Natsugoe S; Berindan-Neagoe I; Calin GA
    Expert Rev Mol Diagn; 2014 Jul; 14(6):673-83. PubMed ID: 24914586
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating microRNAs: a novel class of biomarkers to diagnose and monitor human cancers.
    Zen K; Zhang CY
    Med Res Rev; 2012 Mar; 32(2):326-48. PubMed ID: 22383180
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting microRNAs in epithelial-to-mesenchymal transition-induced cancer stem cells: therapeutic approaches in cancer.
    Garg M
    Expert Opin Ther Targets; 2015 Feb; 19(2):285-97. PubMed ID: 25563894
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potential of microRNAs for cancer diagnostics, prognostication and therapy.
    Garzon R; Marcucci G
    Curr Opin Oncol; 2012 Nov; 24(6):655-9. PubMed ID: 23079782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metastasis-related miRNAs, active players in breast cancer invasion, and metastasis.
    Shi M; Liu D; Duan H; Shen B; Guo N
    Cancer Metastasis Rev; 2010 Dec; 29(4):785-99. PubMed ID: 20938719
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting microRNAs to withstand cancer metastasis.
    Profumo V; Doldi V; Gandellini P; Zaffaroni N
    Methods Mol Biol; 2015; 1218():415-37. PubMed ID: 25319666
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RNA inhibition, microRNAs, and new therapeutic agents for cancer treatment.
    Spizzo R; Rushworth D; Guerrero M; Calin GA
    Clin Lymphoma Myeloma; 2009; 9 Suppl 3():S313-8. PubMed ID: 19778859
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNAs in cancer: biomarkers, functions and therapy.
    Hayes J; Peruzzi PP; Lawler S
    Trends Mol Med; 2014 Aug; 20(8):460-9. PubMed ID: 25027972
    [TBL] [Abstract][Full Text] [Related]  

  • 31. miRNAs in cancer: approaches, aetiology, diagnostics and therapy.
    Blenkiron C; Miska EA
    Hum Mol Genet; 2007 Apr; 16 Spec No 1():R106-13. PubMed ID: 17613543
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urinary microRNAs as a new class of noninvasive biomarkers in oncology, nephrology, and cardiology.
    Mlcochova H; Hezova R; Meli AC; Slaby O
    Methods Mol Biol; 2015; 1218():439-63. PubMed ID: 25319667
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional screening using a microRNA virus library and microarrays: a new high-throughput assay to identify tumor-suppressive microRNAs.
    Izumiya M; Okamoto K; Tsuchiya N; Nakagama H
    Carcinogenesis; 2010 Aug; 31(8):1354-9. PubMed ID: 20525881
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-coding RNAs regulate tumor cell plasticity.
    Liu B; Sun L; Song E
    Sci China Life Sci; 2013 Oct; 56(10):886-90. PubMed ID: 24091685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pre-analytical variables in miRNA analysis.
    Becker N; Lockwood CM
    Clin Biochem; 2013 Jul; 46(10-11):861-8. PubMed ID: 23466658
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Great potential of miRNAs as predictive and prognostic markers for cancer].
    Cho WC
    Zhongguo Fei Ai Za Zhi; 2013 Jan; 16(1):C1-4. PubMed ID: 23677001
    [No Abstract]   [Full Text] [Related]  

  • 37. [Advances of microRNAs correlated with invasion and metastasis of tumors].
    Wang H; Chen X; Wang H; Zhang H
    Zhongguo Fei Ai Za Zhi; 2010 Feb; 13(2):144-8. PubMed ID: 20673508
    [No Abstract]   [Full Text] [Related]  

  • 38. Preface: special issue on microRNAs as novel cancer biomarkers and therapeutic targets.
    Zaffaroni N
    Crit Rev Oncog; 2013; 18(4):v-vi. PubMed ID: 23614623
    [No Abstract]   [Full Text] [Related]  

  • 39. MicroRNA: Potential for Cancer Detection, Diagnosis, and Prognosis.
    Tricoli JV; Jacobson JW
    Cancer Res; 2007 May; 67(10):4553-5. PubMed ID: 17510380
    [No Abstract]   [Full Text] [Related]  

  • 40. Genetic testing for metastasis: potential for improved cancer treatment.
    Aisner DL; Theodorescu D
    Future Oncol; 2011 Jun; 7(6):697-701. PubMed ID: 21675831
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.